Current stage?-Stage III - Page 29 of 33 Posts on Medivizor
Navigation Menu

Current stage?-Stage III Posts on Medivizor

When is the best time to start hormonal therapy for patients with advanced prostate cancer?

When is the best time to start hormonal therapy for patients with advanced prostate cancer?

Posted by on Aug 18, 2013 in Prostate cancer | 0 comments

In a nutshell This study compared the effectiveness of hormonal therapy when used as early, or as late, treatment for patients with advanced prostate cancer. Some background Androgens are hormones (such as testosterone) that are produced mainly in the testicles, and can stimulate the growth of prostate cancer cells. For this reason, androgen...

Read More

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Evaluating outcomes after a local recurrence following breast conserving surgery in young breast cancer patients

Posted by on Aug 15, 2013 in Breast cancer | 0 comments

In a nutshell This study evaluated survival rates after a local recurrence (return of the cancer close to the place of the initial cancer) in young breast cancer patients treated with breast conserving surgery. Some background Young patients with early stage breast cancer are usually treated with breast conserving surgery or BCS (removal of the...

Read More

Bevacizumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer

Bevacizumab plus chemotherapy versus chemotherapy alone in advanced non-small cell lung cancer

Posted by on Aug 9, 2013 in Lung cancer | 0 comments

In a nutshell This study compared two treatment strategies for advanced non-small cell lung cancer: platinum analog chemotherapy plus the drug bevacizumab (avastin) versus platinum analog chemotherapy alone. Some background Treatment for advanced non-small cell lung cancer typically involves treatment with chemotherapy. Standard chemotherapy...

Read More

Phase 2 clinical trial evaluating the safety and efficacy of selumetinib and dacarbazine in patients with advanced melanoma

Phase 2 clinical trial evaluating the safety and efficacy of selumetinib and dacarbazine in patients with advanced melanoma

Posted by on Aug 7, 2013 in Melanoma | 0 comments

In a nutshell This phase 2 clinical trial investigated the safety and efficacy dacarbazine and selumetinib for the treatment of patients who had advanced melanoma with a BRAF mutation.   Some background The BRAF gene makes a protein called B-Raf which is involved in cell growth processes. Approximately 50% of patients with metastatic (cancer...

Read More

Smoking cessation after the diagnosis of lung cancer

Smoking cessation after the diagnosis of lung cancer

Posted by on Aug 4, 2013 in Lung cancer | 0 comments

In a nutshell This review analyzed data collected from recent studies, and estimated the effect of smoking cessation after diagnosis on the outcome of lung cancer patients. Some background Smoking is known to increase the risk of developing lung cancer, as well as other life threatening medical conditions. Quitting smoking after the diagnosis of...

Read More

Relationship between ipilimumab dose and response in patients with advanced melanoma

Relationship between ipilimumab dose and response in patients with advanced melanoma

Posted by on Aug 3, 2013 in Melanoma | 0 comments

In a nutshell This study analyzed the efficacy and safety of ipilimumab (Yervoy) exposure in patients with advanced melanoma. It assessed the relationship between patient response and drug dosage (amount of drug administered) through the minimum steady-state concentration or Cminss (the lowest concentration that the drug reaches before the next...

Read More

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Epoetin alfa improves anemia associated with chemotherapy in breast cancer patients

Posted by on Jul 27, 2013 in Breast cancer | 0 comments

In a nutshell In this study, researchers examined the effect of epoetin alfa (Epogen; Procrit) on anemia (low count of red blood cells) caused by chemotherapy in breast cancer patients. Some background Breast cancer is caused by a defect that makes some breast cancer cells grow and multiply rapidly. One of the treatment options for patients with...

Read More

Evaluating the role of focal therapy in patients with localized prostate cancer

Evaluating the role of focal therapy in patients with localized prostate cancer

Posted by on Jul 22, 2013 in Prostate cancer | 0 comments

In a nutshell This article evaluated which patients can benefit the most from focal therapy (treatments that target only the prostate cancer instead of the entire prostate gland) for prostate cancer. In addition, this research evaluated the effect of this treatment on sexual and bladder function. Some background Treatment which preserves as...

Read More

Colon cancer prognosis is associated with prior smoking and genetic mutations

Colon cancer prognosis is associated with prior smoking and genetic mutations

Posted by on Jul 19, 2013 in Colorectal cancer | 0 comments

In a nutshell This study compared disease free survival (the time period between the end of treatment and until the disease returns or the patient relapses) for colon cancer patients with a history of smoking versus non-smokers. Some background Cigarette smoking can increase the risk of colon cancer. However, it is not clear how prior smoking...

Read More

Neoadjuvant chemotherapy does not reduce survival relative to surgery-first in breast cancer patients

Neoadjuvant chemotherapy does not reduce survival relative to surgery-first in breast cancer patients

Posted by on Jul 13, 2013 in Breast cancer | 0 comments

In a nutshell In this trial researchers examined whether the use of neoadjuvant chemotherapy (before surgery) influenced survival or recurrence rates in women undergoing breast conserving therapy for breast cancer. Some background Neoadjuvant chemotherapy (NCT) refers to chemotherapy treatments received prior to surgery. This approach is often...

Read More